Investigators in the Harper Cancer Research Institute (HCRI) are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. Our programmatic structure fosters multi-disciplinary cancer research by promoting interactions among research groups with distinct expertise and by training young scientists to work across scientific fields. Clinical partnerships provide key translational insight and strengthen the mission of discovery.
HCRI Mission Statement:
Innovative and integrative research confronting the complex challenges of cancer
Normally, the CDC42 gene propels healthy human growth. But when CDC42 is abnormally expressed, it contributes to cancer growth and metastasis. Dr. Tracy Vargo-Gogola, a breast cancer specialist at the Harper Cancer Research Institute, explores both faces of the gene in hopes of developing a better breast cancer treatment.…
Fighting To Stop Tuberculosis
Researchers at the University of Notre Dame are fighting to discover compounds and develop drugs to treat neglected diseases that affect billions of the world’s most vulnerable people.…
Last Friday (Nov. 15), Crislyn D’Souza-Schorey, professor of biological sciences, participated in the Jefferson Educational Society’s Global Summit in Erie, Pa. She gave a presentation titled, “New Insights into Cancer Progression: Biology and Clinical Promise.” Established in 2009, the Global Summit is a week-long series of presentations about broad range of global issues that aim to engage nearly 2,500 attendees in high-level dialogue about these issues.
On Monday, February 24 at 4:00 p.m. in 101 Jordan Hall of Science, Lewis Cantley, the Margaret and Herman Sokol Professor and Director of the Cancer Center at Weill Cornell Medical College/New York Presbyterian Hospital, will give a lecture called, "Targeting PI3K for Cancer Treatment."
The College of Science at the University of Notre Dame is pleased to present the Nieuwland Lectures in Biological Sciences, delivered this year by Dr. Lewis Cantley, the Margaret and Herman Sokol Professor and Director of the Cancer Center at Weill Cornell Medical College/New York Presbyterian Hospital.…
On Tuesday, February 25 at 4:00 p.m. in 283 Galvin Life Science, Lewis Cantley, the Margaret and Herman Sokol Professor and Director of the Cancer Center at Weill Cornell Medical College/New York Presbyterian Hospital, will speak on "Cancer Metabolism."